Canaccord Genuity Maintains Buy on Privia Health Gr, Raises Price Target to $35
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $34 to $35.
Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $34 to $35.